Traws Pharma Inc (TRAW) News

$16.84 halt

$19.44 held resistance 

$17.89 halt tiny resistance at $17.96 then $20 then it's up to $27 blow Santa up

$17.37

$16.40 now 

"In laboratory testing, tivoxavir marboxil inhibited multiple isolates of highly pathogenic avian influenza H5N1. We evaluated the effects of drug treatment in mice exposed to human H5N1, where the virus was isolated from a dairy worker exposed to infected cattle," said C. David Pauza, PhD, Chief Science Officer for Traws Pharma. "Oral treatment with tivoxavir marboxil after the virus infection resulted in complete survival and lung virus levels below the limit of quantitation1. This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza.""Current topline data from our Phase I clinical trial demonstrated safety and tolerability of tivoxavir marboxil, and maintenance of drug levels in blood above the EC90 for longer than 23 days1, with topline data for a higher dose still to come," said Werner Cautreels, PhD, Chief Executive Officer of Traws Pharma. "In addition, the potential for tivoxavir marboxil as a treatment for H5N1 bird flu was demonstrated in an animal model."Topline Phase 1 Results with Tivoxavir Marboxil
The Phase 1 trial was a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics (PK) of ascending doses for one-time tivoxavir marboxil treatment in healthy, influenza-negative, adult volunteers. No treatment-related adverse events were reported during the Phase 1 study. Current topline data from this study showed that a single dose of tivoxavir marboxil maintained plasma drug levels consistently above the EC90 for more than twenty-three days, with topline data for a higher dose still to come. Preclinical studies showed that tivoxavir marboxil demonstrated potent inhibition of drug-resistant influenza viruses, as well as potent inhibition of highly pathogenic bird flu viruses1 both in vitro and in vivo.About H5N1 Bird FluThe virus, also known as Type A H5N1 was detected for the first time in U.S. dairy cattle in March 2024. Since then, bird flu has been confirmed in at least 866 herds in 16 states. More than 60 people in eight states have been infected according to the U.S. Centers for Disease Control and Prevention. Health officials confirmed in December 2024 the first known severe illness in the U.S. caused by bird flu7. The California governor declared a state of emergency as the virus rampages through dairy cattle in that state8.

TRAW: 'Kentucky-Fried-Chicken-Flu', special --- for Xmas LUNCH??? (And remember!! TRAW spelled backwards spells WART!!!)

Just need to cure the chickens lol

In at average 9.80 back out at 12.20s

TRAW: A 'Bird Flu' therapy in the HUMAN, is worth two in the BUSH!! (And 'Bird Flu' is often a very TRAW-matic disease!!)
https://finance.yahoo.com/news/traws-pharma-announces-progress-developing-120000871.html
////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Click below to also see one BIRD that was totally CURED of the 'Bird Flu' infection!! (I.e., it's NOT just Humans!!)
https://www.youtube.com/shorts/Ra_6SqtmEh0